Fusion/Fission Probes Development Service
Mitochondrial fusion and fission are dynamic processes that regulate mitochondrial morphology, energy metabolism, stress response, apoptosis, mitophagy, and mitochondrial quality control. MitoGlowing™ provides a comprehensive Fusion/Fission Probes Development Service to support custom fluorescent probe design, mitochondrial dynamics reporter development, super-resolution imaging-compatible probe optimization, biological validation, and high-content assay workflows for drug screening, cancer research, neurodegenerative disease models, metabolic disease studies, and mitochondrial toxicity evaluation.
Introduction to Fusion/Fission Probes
Mitochondria continuously undergo fusion and fission to maintain a functional and adaptable mitochondrial network. Fusion allows mitochondria to exchange contents, preserve respiratory capacity, and buffer local damage, while fission supports mitochondrial redistribution, damaged mitochondria isolation, mitophagy, apoptosis regulation, and adaptation to cellular stress.
The balance between fusion and fission is regulated by key proteins such as MFN1, MFN2, OPA1, DRP1, MFF, MID49, and MID51. Abnormal mitochondrial dynamics are associated with cancer progression, chemoresistance, neurodegenerative disease, metabolic dysfunction, cardiovascular injury, and drug-induced mitochondrial toxicity.
Fusion/fission probes are designed to visualize mitochondrial morphology, membrane remodeling, electron-flow dynamics, cristae-related changes, fission/fusion sites, mitochondrial network fragmentation, and morphology-linked quality-control events. Advanced probe development can include mitochondria-targeted fluorescent dyes, far-red/NIR probes, morphology-sensitive reporters, electron-flow-responsive probes, SIM-compatible probes, genetically encoded reporters, and high-content image-analysis workflows.
Fig.1 Förster Resonance Energy Transfer Nanoplatform Based on Recognition-Induced Fusion/Fission of DNA Mixed Micelles.
Features of Fusion/Fission Probes Development
- Mitochondrial dynamics-sensitive probe design for mitochondrial network morphology, fusion events, fission events, fragmentation, elongation, cristae-associated remodeling, and quality-control changes.
- Super-resolution imaging compatibility for SIM, confocal microscopy, live-cell imaging, high-content imaging, and long-term time-lapse analysis.
- Mitochondria-targeted probe engineering with mitochondrial localization groups, inner-membrane or matrix retention strategies, low background fluorescence, strong photostability, and multiplex compatibility.
- Morphology and function-linked readouts that connect mitochondrial shape changes with electron flow, proton flow, membrane potential, oxidative stress, cristae structure, or mitochondrial quality-control status.
- High-content quantitative analysis for mitochondrial length, branching, aspect ratio, circularity, fragmentation index, fusion/fission frequency, puncta formation, and network connectivity.
- Application-specific biological validation in cancer drug resistance, neurodegenerative disease, metabolic disease, cardiomyocyte injury, traditional medicine mechanism research, mitochondrial toxicity, and drug screening models.
Our Services
MitoGlowing™ provides an integrated fusion/fission probe development workflow covering project strategy, probe or reporter design, photophysical characterization, mitochondrial dynamics validation, imaging assay development, and application-specific optimization.
Project Design & Mitochondrial Dynamics Readout Strategy
- Define the target application, such as mitochondrial morphology analysis, fusion/fission event tracking, drug screening, cancer drug resistance research, neurodegeneration models, or metabolic disease studies.
- Select the preferred readout format, including morphology-sensitive fluorescent probe, electron-flow-responsive probe, far-red/NIR mitochondrial probe, genetically encoded reporter, or high-content imaging workflow.
- Determine key performance requirements, including mitochondrial localization, photostability, emission wavelength, response kinetics, live-cell compatibility, super-resolution imaging compatibility, and quantitative analysis needs.
- Design validation strategies using fusion/fission modulators, mitochondrial stressors, respiratory chain inhibitors, DRP1 pathway modulators, OPA1/MFN-related models, and mitochondrial damage controls.
Molecular Probe & Reporter Development
- Design mitochondria-targeted probes based on coumarin, rhodamine, cyanine, BODIPY, naphthalimide, hemicyanine, far-red/NIR fluorophores, or customized signal platforms.
- Introduce mitochondrial targeting motifs, inner-membrane retention units, morphology-sensitive response modules, electron/proton-flow-sensitive groups, or ratiometric fluorescence components.
- Develop reporter workflows for mitochondrial morphology, network remodeling, fusion/fission site tracking, cristae-related changes, or mitochondrial quality-control phenotyping.
- Optimize probe permeability, mitochondrial retention, background suppression, photostability, spectral separation, and long-term imaging compatibility.
Photophysical & Functional Characterization
- Measure absorption spectra, emission spectra, excitation/emission maxima, Stokes shift, fluorescence intensity, quantum yield, signal stability, and spectral separation.
- Evaluate photostability, mitochondrial retention, response kinetics, morphology sensitivity, signal-to-background ratio, and compatibility with time-lapse imaging.
- Assess probe performance under mitochondrial elongation, fragmentation, depolarization, oxidative stress, nutrient stress, hypoxia, and drug-induced mitochondrial remodeling.
- Characterize SIM imaging suitability, confocal imaging performance, high-content segmentation quality, and automated morphology-analysis robustness.
Biological Validation & Imaging Assay Development
- Validate mitochondrial localization, network morphology reporting, fusion/fission site visualization, and co-localization with mitochondrial structural markers.
- Optimize staining concentration, incubation time, washing conditions, time-lapse imaging settings, fixation compatibility, plate format, and acquisition parameters.
- Test probe response in models of DRP1 activation or inhibition, MFN1/MFN2-related fusion changes, OPA1-associated inner membrane remodeling, mitochondrial stress, and drug-induced dynamics alteration.
- Establish quantitative analysis methods, including mitochondrial length, branch number, network connectivity, fission/fusion event rate, fragmentation score, puncta count, morphology clustering, and dose-response curves.
Supported Sample Types and Models
- Cancer cell lines, tumor spheroids, organoids, and drug-resistant tumor models
- Mitochondrial dysfunction, oxidative stress, depolarization, and morphology remodeling models
- Neuronal and neurodegenerative disease models, including SH-SY5Y cells, PC12 cells, primary neurons, and brain slices
- Cardiomyocyte models, including H9C2 cells, primary cardiomyocytes, iPSC-derived cardiomyocytes, and high-glucose injury models
- Metabolic disease models, including hepatocytes, adipocytes, fatty acid stress models, and insulin resistance-related systems
- Immune cells, macrophages, renal tubular cells, stem cells, and 3D culture systems
- Drug-treated, hypoxia-treated, oxidative stress-treated, nutrient-stressed, or nanomaterial-treated cells
- Traditional medicine compound-treated cells and natural product screening models
- Tissue sections, zebrafish embryos, and selected small animal research models
- 96-well, 384-well, live-cell imaging, fixed-cell imaging, SIM imaging, and high-content screening formats
Application
Mito-EFT Probe for Mitochondrial Dynamics Imaging and Drug Screening
Mito-EFT-like probes can be used to visualize mitochondrial electron-flow dynamics and connect mitochondrial morphology remodeling with functional quality. SIM-compatible mitochondrial probes can support real-time tracking of fission and fusion processes in individual mitochondria, while high-content analysis can translate imaging phenotypes into drug-screening parameters.
This application supports fusion/fission probe development for mitochondrial dynamics imaging, morphology-function coupling analysis, super-resolution imaging, mitochondrial quality assessment, and mitochondrial-targeted drug screening.
Fusion/Fission Protein Monitoring for Cancer Drug Resistance Research
Mitochondrial fusion and fission proteins are closely linked to tumor stress adaptation, apoptosis escape, and treatment resistance. Probe-based workflows can be combined with MFN1/MFN2, OPA1, DRP1, and MFF-related assays to evaluate how drug-resistant cells remodel their mitochondrial network.
This application supports chemoresistance mechanism analysis, apoptosis escape studies, targeted therapy response evaluation, biomarker discovery, and precision oncology drug development.
Traditional Medicine Mechanism Research and Natural Product Screening
Mitochondria are important targets in traditional medicine mechanism studies because mitochondrial metabolism, oxidative stress, apoptosis, autophagy, and quality control are closely related to many pharmacological effects. Fusion/fission probes can help evaluate whether natural compounds restore mitochondrial dynamics or induce stress-related remodeling.
This application supports natural product screening, traditional medicine modernization, mitochondrial mechanism-of-action studies, oxidative stress regulation, AMPK pathway research, and standardized mitochondrial function-based quality evaluation.
Far-Red/NIR Mitochondrial Probes for Biomedical Imaging
Far-red and NIR mitochondrial probes can reduce autofluorescence, improve tissue penetration, lower phototoxicity, and support long-term observation in complex biological environments. These properties are valuable for monitoring mitochondrial dynamics in cancer, cardiovascular disease, neuronal models, and translational preclinical systems.
This application supports far-red/NIR fusion/fission probe development for cancer imaging, cardiovascular disease models, neuronal mitochondrial studies, drug-induced mitochondrial toxicity evaluation, multicolor imaging, and preclinical translational research.
Our Advantages
- Integrated mitochondrial dynamics probe development: We combine probe design, reporter engineering, photophysical characterization, mitochondrial localization validation, live-cell imaging optimization, and morphology-based quantitative analysis.
- Fusion/fission-focused assay expertise: Our platform supports probe development for mitochondrial network remodeling, fission/fusion site visualization, DRP1-related fragmentation, MFN/OPA1-related fusion, and mitochondrial quality-control phenotyping.
- Super-resolution and high-content compatibility: We support SIM-compatible probes, confocal imaging, live-cell time-lapse imaging, fixed-cell assays, 96-well/384-well imaging workflows, and automated mitochondrial morphology analysis.
- Application-oriented optimization: Probe performance can be tailored for drug screening, cancer drug resistance, neurodegeneration, metabolic disease, traditional medicine research, cardiomyocyte injury, organoids, and mitochondrial toxicity evaluation.
- Multi-parameter mitochondrial QC profiling: Fusion/fission probe assays can be integrated with mitophagy, MitoTimer, mitochondrial membrane potential, ROS, ATP/ADP, NADH/NAD⁺, calcium, pH, apoptosis, cell viability, and mitochondrial morphology assays.
Contact Us
Develop sensitive, stable, and application-specific mitochondrial fusion/fission probes with Protheragen's Fusion/Fission Probes Development Service. Contact us with your target model, preferred imaging platform, fluorescence wavelength, live-cell or fixed-cell requirement, mitochondrial dynamics readout, throughput requirement, and research objective. Our team will recommend a tailored probe or assay development strategy for mitochondrial dynamics imaging, super-resolution analysis, drug screening, cancer resistance research, neurodegenerative disease models, metabolic disease studies, and mitochondrial quality-control profiling.
Reference
1. Vafaei, S., et al. (2021). Förster Resonance Energy Transfer Nanoplatform Based on Recognition-Induced Fusion/Fission of DNA Mixed Micelles for Nucleic Acid Sensing. ACS nano, 15(5), 8517–8524.
